Search

Search Constraints

You searched for: Author/Creator Wei, Xiao X.

Search Results

3. A Phase II Trial of Selinexor, an Oral Selective Inhibitor of Nuclear Export Compound, in Abiraterone‐ and/or Enzalutamide‐Refractory Metastatic Castration‐Resistant Prostate Cancer. (27th February 2018)

4. Activity of cabozantinib after immune checkpoint blockade in metastatic clear-cell renal cell carcinoma. (August 2020)

5. Biomarker-Based Phase II Study of Sapanisertib (TAK-228): An mTORC1/2 Inhibitor in Patients With Refractory Metastatic Renal Cell Carcinoma. (16th February 2022)

6. Development and initial clinical testing of a multiplexed circulating tumor cell assay in patients with clear cell renal cell carcinoma. Issue 9 (3rd March 2021)

7. Exploring new frontiers in prostate cancer research: Report from the 2022 Coffey−Holden prostate cancer academy meeting. Issue 3 (28th November 2022)

9. Prospective Evaluation of Clinical Outcomes Using a Multiplex Liquid Biopsy Targeting Diverse Resistance Mechanisms in Metastatic Prostate Cancer. Issue 26 (10th September 2021)